By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cytonet GmbH & Co. KG 



Weinheim      Germany
Phone: Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
First Data On Cytonet GmbH & Co. KG’s Liver Cell Therapy For Urea Cycle Disorders Presented At The Annual Meeting Of The Society For Inherited Metabolic Disorders (SIMD) 3/11/2014 7:42:28 AM
Cytonet GmbH & Co. KG Submits European Approval Application For Liver Cell Therapy To Treat Urea Cycle Disorders In Children 1/16/2014 10:15:21 AM
Cytonet GmbH & Co. KG Trials Aim to Better Assess Severity of Urea Cycle Disorders Using New Assay for Urea Production 2/15/2012 8:58:02 AM
Cytonet GmbH & Co. KG's Liver Cell Therapy Trial for Children With UCD Expands to Canada 10/19/2011 10:44:01 AM
Cytonet GmbH & Co. KG's Liver Cell Therapy Awarded Orphan Drug Designation for the Treatment of Urea Cycle Disorders 5/18/2011 9:35:11 AM
Cytonet GmbH & Co. KG Release: FDA Approves Innovative Liver Cell Therapy for Clinical Trial in the U.S. 8/10/2010 9:57:55 AM
Cytonet GmbH & Co. KG Release: New Study Examining Therapy Option for the Most Severe Metabolic Disorders in Newborns 4/23/2008 9:01:55 AM
Cytonet GmbH & Co. KG Announce International Collaboration In Cell Therapy 1/16/2007 10:06:54 AM
//-->